Viskase Holdings, Inc.

VISK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009
Revenue $97.9M $51.4M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $49.9M $45.6M
SG&A Expense
Operating Income $-575.0K $-57.1M
Operating Margin -0.6% -111.1%
Interest Expense $6.3M $11.5M
Pretax Income $-3.1M $-59.3M
Income Tax Expense $-337.0K $-2.1M
Net Income $177.2M $683.0K
Net Margin 181.1% 1.3%
EPS (Basic) $0.00 $0.00
EPS (Diluted) $0.00 $0.00
Shares Outstanding (Basic) 58.82B
Shares Outstanding (Diluted) 58.82B
Dividends Per Share $0.00
← Newer Page 3 of 3 Older →